Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial.
about
Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapyCost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trial.Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donors.Contribution of glycosylated recombinant human granulocyte colony-stimulating factor (lenograstim) use in current cancer treatment: review of clinical data.Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications.Granulocyte and erythropoietic stimulating proteins after high-dose chemotherapy for myeloma.Optimal use of G-CSF administration after hematopoietic SCT.Efficacy of deferred dosing of granulocyte colony-stimulating factor in autologous hematopoietic transplantation for multiple myeloma.Lenograstim: a review of its use in chemotherapy-induced neutropenia, for acceleration of neutrophil recovery following haematopoietic stem cell transplantation and in peripheral blood stem cell mobilization.Effects of prophylactic hematopoietic colony stimulating factors on stem cell transplantations: meta-analysis.Early versus late administration of pegfilgrastim after high-dose chemotherapy and autologous hematopoietic stem cell transplantation.Filgrastim XM02 (Tevagrastim®) after autologous stem cell transplantation compared to lenograstim: favourable cost-efficacy analysis.Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients.Administration of G-CSF from day +6 post-allogeneic hematopoietic stem cell transplantation in children and adolescents accelerates neutrophil engraftment but does not appear to have an impact on cost savings.Low-dose lenograstim is as effective as standard dose in shortening neutrophil engraftment time following myeloablative chemotherapy and peripheral blood progenitor cell rescue.
P2860
Q24241680-908E0594-B98A-4FF3-B1CA-CB4E93964768Q33367165-41792BA9-FC01-45A6-B11A-65BF954C856DQ33383573-BC1BB060-1F2E-45F6-97AD-311A9B1E08ADQ33539387-599D43A4-3CDF-4DDB-8796-3C1E5BA129BDQ34620664-8CA7EDC7-EDD1-47F2-8597-1A32B68F5D62Q36936723-B1EF6E68-442C-4A56-831F-BE55D48ACF17Q37442645-D7DF5A5D-133E-4BC6-A1B7-56BB820AA6E5Q37559470-258FCF01-47BE-457E-A3BD-0977748B847BQ37866758-4F3E6FEA-2EF9-4511-B989-FA5A7E5BE993Q40265492-CDA6DA22-7544-47F5-8885-02C7AC60D9B9Q40301448-8BC51E78-EEED-4597-91BB-FDFA75DA7180Q41547224-16D97327-DCE1-4B1A-A7C3-C94458A1EF3AQ44301366-6B0BB882-D28D-4B33-AFFE-73F7B952EB28Q53185657-EE3E82AA-CB33-4ACD-9D34-2C47B9C6F056Q53559619-6F801765-6BD8-46F7-85AA-599CD114FF3D
P2860
Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Lenograstim after autologous p ...... ouble-blind, randomized trial.
@en
Lenograstim after autologous p ...... ouble-blind, randomized trial.
@nl
type
label
Lenograstim after autologous p ...... ouble-blind, randomized trial.
@en
Lenograstim after autologous p ...... ouble-blind, randomized trial.
@nl
prefLabel
Lenograstim after autologous p ...... ouble-blind, randomized trial.
@en
Lenograstim after autologous p ...... ouble-blind, randomized trial.
@nl
P2093
P2860
P356
P1476
Lenograstim after autologous p ...... ouble-blind, randomized trial.
@en
P2093
Caballero D
Cordonnier C
Delabarre F
Linkesch W
Littlewood T
P2860
P2888
P304
P356
10.1038/SJ.BMT.1704724
P407
P50
P577
2004-12-01T00:00:00Z